추가 설명:
This isotopically labelled standard (13C4,15N2-5-fluorouracil, MW 136.03) supports testing related to 5-fluorouracil, one of the most widely administered solid-tumor chemotherapy agents, whose severe toxicity risk, driven mainly by dihydropyrimidine dehydrogenase (DPD) enzyme deficiency, makes pretreatment assessment essential.
평가 & 댓글 남기기